Value of Ultrasonographic Enthesitis Assessment in Spondyloarthritis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04946539

Enrollment

Registered

2021-07-01

Start date

2016-11-30

Completion date

2017-03-31

Last updated

2021-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enthesitis, Spondyloarthritis

Brief summary

The aim of the study is to determine how valuable ultrasonographic enthesitis to asssess disease activity, functionality and quality of life.

Interventions

DIAGNOSTIC_TESTUltrasonography

Enthesitis assessment via ultrasonography

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Inclusion criteria

* Spondyloarthritis patients that fulfill 2009 ASAS criteria

Exclusion criteria

* history of elbow, ankle or knee surgery, local injection at the examination sites within the six weeks, peripheral neuropathy, infection and wound at examination site

Design outcomes

Primary

Measure	Time frame	Description
Disease activity,	between November 2016 and January 2017	BASDAI (Bath Ankylosing Spondylitis Disease Activity Index), minimum value 0, maximum value 10, higher scores mean a worse outcome
functionality	between November 2016 and January 2017	Bath Ankylosing Spondylitis Functionality Index (BASFI). Minimal values 0, maximum value 100. Higher scores mean a worse outcome
to measure quality of life	between November 2016 and January 2017	Short Form - 12 (SF-12). minimum value 0 maximum value 100. higher scores mean a worse outcome

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026